Polycythemia - Causes, Treatment & When to See a Doctor

```html

What is Polycythemia?

Polycythemia is a condition in which the body produces too many red blood cells (RBCs), leading to an abnormally high hematocrit (the proportion of blood made up of RBCs) and a raised hemoglobin level. The excess cells make the blood more viscous (thicker), which can impair circulation and increase the risk of clotting, headache, and fatigue. Polycythemia can be primary (the bone marrow itself is overactive) or secondary

Common Causes

Below are the most frequently encountered conditions and situations that lead to polycythemia. Both primary and secondary forms are included.

• Polycythemia Vera (PV) – A myeloproliferative neoplasm caused by a JAK2 gene mutation; the bone marrow makes excess RBCs, white cells, and platelets.
• Chronic Hypoxia – Low oxygen levels stimulate erythropoietin (EPO) production (e.g., chronic obstructive pulmonary disease, interstitial lung disease, severe asthma).
• High‑Altitude Living – Sustained exposure to reduced atmospheric oxygen prompts the kidneys to release more EPO.
• Obstructive Sleep Apnea (OSA) – Repeated nighttime hypoxia causes intermittent EPO spikes.
• Congenital Heart Disease – Cyanotic heart lesions (e.g., Tetralogy of Fallot) shunt deoxygenated blood, driving compensatory RBC production.
• Renal Tumors or Cysts – Certain kidney cancers secrete EPO autonomously.
>
• Paraneoplastic Syndromes – Some lung, breast, or gastrointestinal cancers produce ectopic EPO.
• Smoking – Carbon monoxide reduces oxygen delivery, prompting compensatory polycythemia.
• Dehydration – Loss of plasma volume concentrates RBCs, falsely elevating hematocrit (relative polycythemia).
• Use of Anabolic Steroids or Testosterone Therapy – Hormonal stimulation can increase red‑cell mass.

Associated Symptoms

Because the blood becomes thicker, many patients notice a mix of vascular and systemic complaints. Commonly reported features include:

• Headache, especially after waking or exertion
• Dizziness or light‑headedness
• Flushed or ruddy complexion (“plethoric” face)
• Itching (pruritus), particularly after a warm shower (more typical in PV)
• Fatigue and reduced exercise tolerance
• Blurred vision or visual disturbances
• Chest pain or angina‑like discomfort due to reduced coronary flow
• Tingling, numbness, or a “pins‑and‑needles” sensation in the hands and feet (erythromelalgia)
• Unexplained weight loss (often seen in myeloproliferative disorders)
• History of blood clots (deep‑vein thrombosis, pulmonary embolism, stroke)

When to See a Doctor

Any of the following warrants prompt medical evaluation:

• Persistent or worsening headache, especially if associated with visual changes.
• Sudden shortness of breath, chest pain, or palpitations.
• Swelling, pain, or redness in a limb that could indicate a blood clot.
• Frequent unexplained bruising or bleeding.
• New or worsening itching after a hot shower.
• Symptoms of sleep apnea (loud snoring, witnessed pauses, daytime sleepiness) that have not been addressed.
• Any concern after a routine blood test shows a hematocrit >52% in men or >48% in women.

Diagnosis

Diagnosing polycythemia involves a combination of history, physical examination, and targeted laboratory tests.

Step‑by‑step evaluation

1. Complete Blood Count (CBC) – The initial clue is an elevated hemoglobin and hematocrit. The RBC count, mean corpuscular volume (MCV), and platelet/white‑cell counts help differentiate primary from secondary causes.
2. Erythropoietin (EPO) level – Low or suppressed EPO suggests primary polycythemia (e.g., PV). Elevated EPO points to secondary causes such as hypoxia or tumor‑derived EPO.
3. JAK2 Mutation Testing – Over 95% of PV patients have the JAK2 V617F mutation; a smaller proportion have JAK2 exon 12 mutations.
4. Oxygen Saturation & Arterial Blood Gas – Low PaO₂ or O₂ saturation supports a hypoxia‑driven etiology.
5. Chest Imaging (CT or X‑ray) – Evaluates lung disease or high‑altitude‑related changes.
6. Sleep Study (Polysomnography) – Recommended if obstructive sleep apnea is suspected.
7. Renal Imaging (Ultrasound/CT) – Looks for renal masses or cysts that could secrete EPO.
8. Bone Marrow Biopsy – Reserved for ambiguous cases; shows hypercellularity with erythroid predominance in PV.

Once the underlying cause is identified, treatment can be tailored appropriately.

Treatment Options

Treatment strategies differ between primary (PV) and secondary polycythemia, but the overarching goals are to reduce blood viscosity, prevent thrombosis, and address the root cause.

Medical Interventions

• Phlebotomy – Regular removal of 500 mL of blood (≈1 unit) lowers hematocrit to < 45% in men and < 42% in women. This is the cornerstone for PV and many secondary cases.
• Aspirin (Low‑dose, 81 mg daily) – Decreases platelet aggregation and clot risk; routinely prescribed unless contraindicated.
• Hydroxyurea – A cytoreductive agent used when phlebotomy alone cannot keep hematocrit in target range or when thrombotic risk is high.
• Interferon‑α – An alternative to hydroxyurea, especially for younger patients or those planning pregnancy.
• JAK2 Inhibitors (e.g., ruxolitinib) – Approved for PV patients who are resistant or intolerant to hydroxyurea.
• EPO‑targeted therapy – In secondary polycythemia caused by excess EPO (e.g., renal tumors), surgical removal or targeted cancer therapy can resolve the problem.
• Continuous Positive Airway Pressure (CPAP) – First‑line for obstructive sleep apnea, reducing nocturnal hypoxia.
• Supplemental Oxygen – Utilized for chronic lung disease or high‑altitude exposure when oxygen saturation remains low despite other measures.

Home & Lifestyle Measures

• Maintain adequate hydration – aim for ≥ 2 L of fluid per day unless fluid‑restricted for heart/kidney disease.
• Quit smoking – eliminates carbon‑monoxide‑induced hypoxia.
• Avoid excessive alcohol, which can worsen dehydration.
• Engage in regular moderate‑intensity aerobic activity (e.g., brisk walking 150 min/week) to improve circulation.
• Wear compression stockings if you have a history of leg swelling or venous insufficiency.
• Monitor weight and blood pressure; uncontrolled hypertension compounds clot risk.

Prevention Tips

While primary polycythemia cannot be prevented, many secondary forms are modifiable.

• Manage Chronic Lung Disease – Follow inhaler regimens, get vaccinations (influenza, pneumococcal), and attend pulmonary rehab.
• Screen and Treat Sleep Apnea – Use CPAP consistently; lose weight if overweight.
• Limit High‑Altitude Exposure – If you must travel to high elevations, ascend gradually and consider prophylactic acetazolamide after consulting a physician.
• Stay Hydrated – Dehydration can mimic polycythemia; drink water regularly, especially during hot weather or exercise.
• Avoid Unnecessary Testosterone or Anabolic Steroids – Use only under medical supervision.
• Regular Health Checks – Annual CBCs for people with risk factors (smoking, COPD, OSA) help catch rising hematocrit early.

Emergency Warning Signs

Key Take‑aways

Polycythemia is a serious but treatable condition. Recognizing the signs—persistent headaches, flushing, pruritus, or unexplained clotting events—can lead to early diagnosis. Laboratory testing, especially a CBC, JAK2 mutation analysis, and EPO level, clarifies whether the problem is primary (PV) or secondary (e.g., hypoxia, tumor‑derived EPO). Treatment ranges from simple phlebotomy and low‑dose aspirin to targeted medications like hydroxyurea or ruxolitinib. Lifestyle changes such as quitting smoking, staying hydrated, and treating sleep apnea are essential adjuncts.

Because thickened blood can precipitate life‑threatening clots, never ignore the emergency warning signs listed above. When in doubt, seek medical care promptly.

Sources: Mayo Clinic, National Institutes of Health (NIH) – PubMed, American Society of Hematology, Centers for Disease Control and Prevention (CDC), World Health Organization (WHO), Cleveland Clinic.

```